Atlas Trials

Gray Zone Lymphoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gray Zone Lymphoma

RecordFirmDate
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma (NCT05208853)Zhejiang University2022-02-10
A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma (NCT04860674)Zhejiang Cancer Hospital2021-05-01
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma (NCT04231877)University of Washington2020-10-27
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL (NCT03602157)UNC Lineberger Comprehensive Cancer Center2018-10-29
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine (NCT02996773)University of Arizona2016-11-29
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma (NCT01943682)Children's Hospital Medical Center, Cincinnati2013-09-01
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NCT00001337)National Cancer Institute (NCI)1993-05-08

Track Gray Zone Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.